High Cholesterol Completed Phase 2 Trials for Atorvastatin (DB01076)

Also known as: High Blood Cholesterol Level / Hypercholesterolemia / Hypercholesteremia / Hypercholesterolaemia / Congenital xanthoma / Hypercholesteraemia / Elevated cholesterol

IndicationStatusPhase
DBCOND0037835 (High Cholesterol)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01779453A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaTreatment
NCT00687271A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)Treatment
NCT03051100Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CTreatment
NCT00474240AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate HypercholesterolemiaTreatment
NCT00690443Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in HypercholesterolemiaTreatment
NCT00133380A Study in People With High CholesterolTreatment
NCT00166036Effect of Statins on Oxidative Stress and Endothelial Progenitor CellsTreatment
NCT01812707Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in JapanTreatment
NCT02591836Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With AtorvastatinTreatment
NCT02608697A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With HypercholesterolemiaTreatment
NCT00864643Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaTreatment
NCT01288469Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary HypercholesterolemiaTreatment
NCT01288443Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin TherapyTreatment
NCT01279590Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)Treatment